38 related articles for article (PubMed ID: 14996746)
1. Fluorescent Orthotopic Mouse Model of Pancreatic Cancer.
Moreno JA; Sanchez A; Hoffman RM; Nur S; Lambros MP
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27685334
[TBL] [Abstract][Full Text] [Related]
2. Application of GFP imaging in cancer.
Hoffman RM
Lab Invest; 2015 Apr; 95(4):432-52. PubMed ID: 25686095
[TBL] [Abstract][Full Text] [Related]
3. Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model.
Sato K; Choyke PL; Kobayashi H
PLoS One; 2014; 9(11):e113276. PubMed ID: 25401794
[TBL] [Abstract][Full Text] [Related]
4. Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.
Lim MY; Jamieson K
Clin Interv Aging; 2014; 9():753-62. PubMed ID: 24851045
[TBL] [Abstract][Full Text] [Related]
5. Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.
Qiu W; Su GH
Cancer Metastasis Rev; 2013 Jun; 32(1-2):83-107. PubMed ID: 23114842
[TBL] [Abstract][Full Text] [Related]
6. Sapacitabine for cancer.
Liu X; Kantarjian H; Plunkett W
Expert Opin Investig Drugs; 2012 Apr; 21(4):541-55. PubMed ID: 22329458
[TBL] [Abstract][Full Text] [Related]
7. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.
Tran Cao HS; Bouvet M; Kaushal S; Keleman A; Romney E; Kim G; Fruehauf J; Imagawa DK; Hoffman RM; Katz MH
Mol Cancer Ther; 2010 Jul; 9(7):2068-78. PubMed ID: 20606044
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model.
Erten A; Wrasidlo W; Scadeng M; Esener S; Hoffman RM; Bouvet M; Makale M
Nanomedicine; 2010 Dec; 6(6):797-807. PubMed ID: 20599526
[TBL] [Abstract][Full Text] [Related]
9. Lost in migration.
Mack GS; Marshall A
Nat Biotechnol; 2010 Mar; 28(3):214-29. PubMed ID: 20212481
[No Abstract] [Full Text] [Related]
10. Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins.
Hoffman RM
Clin Exp Metastasis; 2009; 26(4):345-55. PubMed ID: 18787963
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.
Tong Z; Kunnumakkara AB; Wang H; Matsuo Y; Diagaradjane P; Harikumar KB; Ramachandran V; Sung B; Chakraborty A; Bresalier RS; Logsdon C; Aggarwal BB; Krishnan S; Guha S
Cancer Res; 2008 Aug; 68(15):6100-8. PubMed ID: 18676832
[TBL] [Abstract][Full Text] [Related]
12. Synthetic extracellular matrix enhances tumor growth and metastasis in an orthotopic mouse model of pancreatic adenocarcinoma.
Scaife CL; Shea JE; Dai Q; Firpo MA; Prestwich GD; Mulvihill SJ
J Gastrointest Surg; 2008 Jun; 12(6):1074-80. PubMed ID: 18057994
[TBL] [Abstract][Full Text] [Related]
13. Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.
Grzesiak JJ; Smith KC; Burton DW; Deftos LJ; Bouvet M
Surgery; 2007 Jun; 141(6):804-14. PubMed ID: 17560257
[TBL] [Abstract][Full Text] [Related]
14. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2004 Mar; 64(5):1828-33. PubMed ID: 14996746
[TBL] [Abstract][Full Text] [Related]
15. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
[TBL] [Abstract][Full Text] [Related]
17. High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model.
Wu M; Mazurchuk R; Chaudhary ND; Spernyak J; Veith J; Pera P; Greco W; Hoffman RM; Kobayashi T; Bernacki RJ
Cancer Res; 2003 May; 63(10):2477-82. PubMed ID: 12750269
[TBL] [Abstract][Full Text] [Related]
18. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
